Clinical Trials Directory

Trials / Completed

CompletedNCT04558645

Evaluation of Quality of Life in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic

Evaluation of Quality of Life, Physical Activity and Depression in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic

Status
Completed
Phase
Study type
Observational
Enrollment
118 (actual)
Sponsor
Gazi University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

During the COVID-19 pandemic, the time spent at the home of patients has increased because of national quarantine policies and patients' fear of getting sick. For this reason, in this ongoing process, patients have been unable to go to work regularly due to their chronic diseases (being on administrative leave) and their fear of going out. These reasons have prevented being physically active. The aim of the study is to evaluate the physical activity level, quality of life, glucose control, anxiety, depression, fear of hypoglycemia and loneliness perceptions of patients with type 1 diabetes mellitus during the COVID-19 pandemic period and compared with healthy controls.

Conditions

Interventions

TypeNameDescription
OTHEROnline SurveyOnline surveys will be applied to all participants

Timeline

Start date
2020-09-18
Primary completion
2020-12-18
Completion
2020-12-26
First posted
2020-09-22
Last updated
2020-12-29

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04558645. Inclusion in this directory is not an endorsement.